BioAgilytix Rebrands Its Cambridge Biomedical Diagnostic Testing Division to BioAgilytix Diagnostics

The Latest News from BioAgilytix

BioAgilytix leadership - Dr. Chad Briscoe
June 30, 2020

Chad Briscoe, Ph.D. Joins BioAgilytix Leadership Team as Chief Scientific Officer

In this role, Dr. Briscoe will provide scientific and regulatory oversight to BioAgilytix’s global teams with strategic guidance in line with emerging scientific developments.

Read More

Mike Nicholson, Ph.D. Vice President, Operations
June 25, 2020

BioAgilytix Welcomes Mike Nicholson, Ph.D. to Leadership Team as Vice President, Operations

In this role, Dr. Nicholson will oversee bioanalytical operations and scientific team development across BioAgilytix’s laboratories in both the USA and Europe, with particular focus leading the organization’s Gene and Cell Therapy bioanalytical services.

Read More

COVID-19 testing packages
June 9, 2020

BioAgilytix Launches Customizable Testing Packages Supporting Solutions to Treat and Prevent Spread of COVID-19

BioAgilytix is now offering customizable COVID-19 testing packages with services to address a breadth of sponsor and employer needs stemming from the coronavirus pandemic.

Read More

Frank Horling, Ph.D. Joins BioAgilytix
May 6, 2020

Frank Horling, Ph.D. Joins BioAgilytix Leadership Team as General Manager, Europe

In this role, Dr. Horling will lead Operations, Finance, HR, and Facilities for BioAgilytix’s European business and its laboratory located in Hamburg, Germany.

Read More

BioAgilytix Expert: Jim McNally, Ph.D
April 29, 2020

BioAgilytix Welcomes Jim McNally, Ph.D. to Leadership Team as Chief Scientific Officer

Dr. McNally brings with him an extensive background in bioanalytical assay development and program leadership working for almost 20 years in the pharmaceutical and biotechnology industry.

Read More